Rivaroxaban vs Tofacitinib

## Rivaroxaban vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Rivaroxaban** and **Tofacitinib**.

## Mechanism of Action

**Rivaroxaban**: Direct Factor Xa inhibitor.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Rivaroxaban — 5-9 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Rivaroxaban — C19H18ClN3O5S; Tofacitinib — C16H20N6O.

**Molecular Weight**: Rivaroxaban — 435.8820 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Rivaroxaban — Small molecule; Tofacitinib — Small molecule.